Skip to main content
. Author manuscript; available in PMC: 2012 Sep 1.
Published in final edited form as: Toxicol Appl Pharmacol. 2011 Jun 25;255(2):200–206. doi: 10.1016/j.taap.2011.06.017

Figure 3.

Figure 3

The anti-hypotensive effect of TCC in a LPS-challenged murine model. LPS (10 mg/kg) and TCC (5 mg/kg) were administered to male Swiss-Webster mice (8-week old) with i.p. injection and oral gavage, respectively. Systolic blood pressure was recorded 8-h and 24-h after treatment with a non-invasive tail cuff method. Data represent mean ± SD of 4 mice. If the systolic blood pressure was under the detection limit of instrument (60 mmHg), the value was recorded as 60 mmHg. Data represent mean ± SD of 6 mice. Animals were sacrificed 8 and 24-h after treatment, respectively. Control (CTL) was saline, and vehicle (VEH) was oleic acid rich triglycerides containing 10% PEG400 (v/v) and 10% ethanol (v/v); mpk: mg/kg. Statistically significant differences (*P<0.05, **P<0.01)) were determined by ANOVA followed with Tukey’s.